Logo image
Back
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation
Journal article   Open access   Peer reviewed

Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation

K Shekar, J A Roberts, C I McDonald, S Fisquet, A G Barnett, D V Mullany, S Ghassabian, S C Wallis, Yoke Lin Fung, M T Smith, …
Critical Care, Vol.16(5), R194
2012
DOI: https://doi.org/10.1186/cc11679
pdf
PDF - Published Version (Open Access)386.73 kBDownloadView
Published VersionPDF - Published Version (Open Access)CCBY_V2.0,  Open Access
url
https://doi.org/10.1186/cc11679View
Published Version

Abstract

Introduction: Extracorporeal membrane oxygenation (ECMO) is a supportive therapy, with its success dependent on effective drug therapy that reverses the pathology and/or normalizes physiology. However, the circuit that sustains life can also sequester life-saving drugs, thereby compromising the role of ECMO as a temporary support device. This ex vivo study was designed to determine the degree of sequestration of commonly used antibiotics, sedatives and analgesics in ECMO circuits.Methods: Four identical ECMO circuits were set up as per the standard protocol for adult patients on ECMO. The circuits were primed with crystalloid and albumin, followed by fresh human whole blood, and were maintained at a physiological pH and temperature for 24 hours. After baseline sampling, fentanyl, morphine, midazolam, meropenem and vancomycin were injected into the circuit at therapeutic concentrations. Equivalent doses of these drugs were also injected into four polyvinylchloride jars containing fresh human whole blood for drug stability testing. Serial blood samples were collected from the ECMO circuits and the controls over 24 hours and the concentrations of the study drugs were quantified using validated assays.Results: Four hundred samples were analyzed. All study drugs, except meropenem, were chemically stable. The average drug recoveries from the ECMO circuits and the controls at 24 hours relative to baseline, respectively, were fentanyl 3% and 82%, morphine 103% and 97%, midazolam 13% and 100%, meropenem 20% and 42%, vancomycin 90% and 99%. There was a significant loss of fentanyl (p = 0.0005), midazolam (p = 0.01) and meropenem (p = 0.006) in the ECMO circuit at 24 hours. There was no significant circuit loss of vancomycin at 24 hours (p = 0.26).Conclusions: Sequestration of drugs in the circuit has implications on both the choice and dosing of some drugs prescribed during ECMO. Sequestration of lipophilic drugs such as fentanyl and midazolam appears significant and may in part explain the increased dosing requirements of these drugs during ECMO. Meropenem sequestration is also problematic and these data support a more frequent administration during ECMO. © 2012 Shekar et al.; licensee BioMed Central Ltd.

Details

Metrics

49 File views/ downloads
693 Record Views
229 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Critical Care Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image